# FMT Capsules for rCDI

> **NCT07458984** · PHASE3 · RECRUITING · sponsor: **Helsinki University Central Hospital** · enrollment: 76 (estimated)

## Conditions studied

- Clostridioides Difficile Infection Recurrence
- FMT

## Interventions

- **BIOLOGICAL:** Healthy donor stool
- **BIOLOGICAL:** placebo capsule

## Key facts

- **NCT ID:** NCT07458984
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-25
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07458984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07458984, "FMT Capsules for rCDI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07458984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*